Date de publication: 1 août 2024
Promoteur – Intermédiaire Financier
CREDIT AGRICOLE SALieu
Description
The operation is structured as multiple beneficiary intermediated loan (MBIL) to Crédit Agricole to support projects in the French healthcare industry carried out by small and medium sized enterprises (SMEs), including professionals.
Additionality and Impact
The project aims to increase access to finance for SMEs and professionals operating in the healthcare and medical sectors in France, with a focus on new business installations (clinics, medical studios, etc.) and gender equality.
Therefore, this operation will contribute to supporting the Bank's priority objectives in terms of SME support, health, and gender equality. Additionally, up to 90% of EIB funds are expected to be channelled to French cohesion (transition) regions, as per the Financial Intermediary (FI)'s historical track record.
The EIB loan will target in particular healthcare practitioners willing to install their own business, thus helping to better distribute healthcare services across France and fight against the so-called "medical deserts" impacting roughly 9 million people in France. Moreover, with a minimum of 30% of EIB funds to be allocated to businesses run by women or offering women quality employment or dedicated products and services, the project is also expected to support women's presence in the sector.
The operation supports as well the FI's intervention in the healthcare sector, by facilitating its lending to some targeted investments. The FI is financially sound and has a sufficient track record of implementing and allocating EIB products.
The EIB intervention will enhance access to finance for final beneficiaries and improve financing conditions for them as the FI will need to transfer a minimum financial advantage in its contractual conditions. Furthermore, additional flexibility is provided in terms of drawdowns and repayment profile, hence mirroring the economic life of the investments.
Objectifs
The aim is to enhance access to finance to SMEs and entrepreneurs in the French healthcare system. Up to 50% of the MBIL total amount will support new start-ups in the sector and 30% to enterprises run by women.
Secteur(s)
- Lignes de crédit - Lignes de crédit
Montant BEI envisagé (montant approximatif)
EUR 400 million
Coût total (montant approximatif)
not applicable
Aspects environnementaux
Final beneficiaries will be requested to comply with applicable national and EU legislation, as appropriate.
Passation des marchés
Final beneficiaries will be requested to comply with applicable national and EU legislation, as appropriate.
Statut
Signé - 30/07/2024
Clause de non-responsabilité
Avant d’être approuvés par le Conseil d’administration et avant la signature des prêts correspondants, les projets font l’objet d’une instruction et de négociations. Par conséquent, les informations et données fournies sur cette page sont indicatives.
Elles sont fournies à des fins de transparence uniquement et ne peuvent être considérées comme représentant la politique officielle de la BEI (voir également les notes explicatives).